Concepedia

Jianling Li

JL

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

2006

Affiliations

Pharmacyclics (United States)(Current)

AbbVie (United States)

Sorbonne Université

Dana-Farber Cancer Institute

Assistance Publique – Hôpitaux de Paris

Jianling Li is an author at Pharmacyclics (United States) specializing in pharmacology, immunotherapy, and pharmacy.

ORCID

Publications per year

2006–2021

6

Publications

6

Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

Steven P. Treon, Christina Tripsas, Kirsten Meid et al. · New England Journal of Medicine · 2015 · 931 citations · Full text

, , +13

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

Anna S. Lok, David Gardiner, Christophe Hézode et al. · Journal of Hepatology · 2013 · 139 citations

, , +14

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with <i>TP53</i> aberrations: a pooled analysis from four clinical trials

John N. Allan, Tait D. Shanafelt, Adrian Wiestner et al. · British Journal of Haematology · 2021 · 64 citations · Full text

, , +12

Vaginal Nystatin Versus Oral Fluconazole for the Treatment for Recurrent Vulvovaginal Candidiasis

Shang­rong Fan, Xiaoping Liu, Cong Wu et al. · Mycopathologia · 2014 · 47 citations

, , +14

Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus–Coinfected Subjects With Hepatic Impairment

Joanna Peng, Federico Pulido, Sonja J. Causemaker et al. · The Journal of Clinical Pharmacology · 2006 · 45 citations

, , +15

1–5 of 6